Completed

Piracetam for Treatment of Cocaine Addiction - 3

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Piracetam

Drug
Who is being recruted

Cocaine-Related Disorders

From 21 to 45 Years

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 1
Interventional
Study Start: October 1996

See protocol details

Summary

Principal SponsorUniversity of Pennsylvania
Last updated: October 6, 2015
Sourced from a government-validated database.Claim as a partner
Study start date: October 1, 1996Actual date on which the first participant was enrolled.

The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.

Official TitlePiracetam for Treatment of Cocaine Addiction 
Principal SponsorUniversity of Pennsylvania
Last updated: October 6, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
MaleBiological sex of participants that are eligible to enroll.
From 21 to 45 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Cocaine-Related Disorders
Criteria

Please contact site for information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives
Study Objectives
Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Suspended
University of PennsylvaniaPhiladelphia, United StatesSee the location
CompletedOne Study Center